About Us - Pharma Form Finder

Turning Molecular Challenges
into Stable, Market-Ready Medicines

• Who We Are

A Lifetime Dedicated to Unlocking the Secrets of Crystals.

Greg Stephenson was born in Anderson, Indiana in 1962. After obtaining a B.S. in Chemistry from Ball State University, he earned a Ph.D. in Medicinal Chemistry from Purdue University for research of the solid-state properties of pharmaceuticals under the advisement of Professor Stephen Byrn. He subsequently joined Eli Lilly and Company in its Material Science and Physical Characterizations group in 1994.

He is currently a Research Advisor to the Preformulation Department, where he is responsible for the company’s small molecule X-ray crystallography laboratory and its Salt Screening groups. He was the recipient of Eli Lilly and Company’s Presidential Award in 1995, 1997, 2004, and 2012. He has authored more than 70 peer-reviewed journal articles, is named as co-inventor on 14 different patents, and has authored three book chapters. He was elected as a Fellow of the International Centre for Diffraction’s awards committee. He serves on the Editorial Advisor Board for The Journal of Pharmaceutical Sciences and Pharmaceutical Development and Technology and also reviews articles for numerous journals. He continues to be fascinated by the crystallization behavior of organic compounds and continues to venture into the laboratory on every possible opportunity.

• Highlight

0 +


Clients

0 +


Facilities

0 +


Years of experience
• Core Values

Our Core Value

Safety

We maintain the highest standards of scientific and laboratory safety, ensuring that every experiment, analysis, and process is performed with precision and care. The well-being of our team, partners, and the patients ultimately served by our work is our top priority.

Innovation

We advance pharmaceutical development through continuous scientific discovery. By exploring novel solid forms, crystallization pathways, and analytical approaches, we push the boundaries of what’s possible in solid-state chemistry and preformulation science.

Integrity

We conduct our research and collaborations with complete transparency, scientific rigor, and ethical responsibility. Our commitment to honest data, reliable results, and unbiased guidance builds enduring trust with every client and partner.

Customer Focus

We are dedicated to understanding the unique challenges of each molecule and each client. By delivering tailored solid-form solutions, actionable insights, and responsive scientific support, we help our partners accelerate development and achieve confident outcomes.

• Work History
  • Eli Lilly and Company 2013 - Product Design and Developability, Research Advisor
  • Eli Lilly and Company 2005 - 2013 Preformulation Department, Research Advisor
  • Eli Lilly and Company 1999 - 2004 Research Scientist
  • Pharmaceutical Research and Development Division

A Career Built on Mastering the Solid State of Pharmaceuticals

Eli Lilly and Company 1994 - 1998 Senior Scientist

Pharmaceutical and Analytical Development Division Material Science and Physical Characterizations Group.

Purdue University 1990 - 1994 Research Assistant

Studied under the advisement of Dr. Stephen R. Byrn, Area of Specialization: Polymorphism and Analytical Chemistry of...

Eli Lilly and Company 1986 - 1990 Associate Analytical Chemist

Analytical Chemist responsible for the X-ray Powder Diffraction and Thermal Analytical methods in Analytical Development.

• Education
  • Ph.D. from Purdue University, Medicinal Chemistry, 1994

  • Graduate Research Advisor: Dr. Stephen Byrn (now in Industrial and Physical Pharmacy)

  • B.S. in Chemistry from Ball State University

• Awards

Awards & Accomplishments

01 Editorial Advisory Board Member for the Journal of Pharmaceutical Sciences 2004–2015
02 Editorial Advisory Board Member for Pharmaceutical Development and Technology 2011–2015
03 Recipient of Eli Lilly and Company’s Presidential Award in 2012.
04 Recipient of Eli Lilly and Company’s Presidential Award in 2004.
05 ICDD, elected Fellow by the International Committee for Diffraction Data’s Awards Committee, 2000.
06 Chairman of Organic and Pharmaceutical Compound Subcommittee 1998–2004.
07 Recipient of Eli Lilly and Company’s Presidential Award in 1998
08 Recipient of Eli Lilly and Company’s Presidential Award in 1997.
09 Elected member of the International Centre for Diffraction Data (ICDD), 1997.
10 Recipient of Eli Lilly and Company’s Presidential Award in 1995.
11 United States Pharmacopeial Convention (USP) Research Fellowship 1992–1994.
12 Member of Rho Chi, the national honor society for Pharmaceutical Sciences.
• Affiliations

Strengthening Science Through Global Collaboration

  • Editorial Advisory Board Member for the Journal of Pharmaceutical Sciences 2004–2013
  • ICDD, elected Fellow by International Committee for Diffraction Data’s Awards Committee, 2000
  • Elected member of the International Centre for Diffraction Data (ICDD), 1997
  • Member of Rho Chi, the national honor society for Pharmaceutical Sciences
  • Member of the American Crystallographic Association
  • Editorial Advisory Board Member for Pharmaceutical Development and Technology 2011–2013
  • hairman of Organic and Pharmaceutical Compound Subcommittee 1998–2004
  • United States Pharmacopeial Convention (USP) Research Fellowship 1992–1994
  • Member of the American Association of Pharmaceutical Sciences
• Journals

A Recognized Voice in Reviewing Breakthroughs in Solid-State and Pharmaceutical Science

Reviewer for: Crystal Growth and Design, Journal of Pharmaceutical Science, Expert Opinion on Drug and Metabolism & Toxicology, Pharmaceutical Development and Technology, Journal of Pharmaceutical and Biomedical Analysis, Pharmaceutical Research, Chemical Research in Toxicology, Pharmaceutical Development and Technology, and Molecular Pharmaceutics

• Testimonials
• FAQs

Frequently Asked Questions

Primarily pharmaceutical companies involved in small-molecule drug development.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

• Contact Us

Talk to an Expert Today

Fill out the form below, and we’ll schedule a consultation to discuss your solid-state challenges.